(Q64869450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

A G Hempel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M A Maaty

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J I Sage

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

878-883

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.

5 December 2019

cites work

1 reference

Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease

21 January 2018

1 reference

A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance

21 January 2018

1 reference

Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa.

21 January 2018

1 reference

Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study

21 January 2018

1 reference

Nighttime levodopa infusions to treat motor fluctuations in advanced parkinson's disease: Preliminary observations

21 January 2018

1 reference

Clinical and pharmacokinetic evaluation of controlled-release levodopa/carbidopa (CR-4) in parkinsonian patients with severe motor fluctuations: a six month follow-up study.

21 January 2018

1 reference

Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group

21 January 2018

1 reference

Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease--an open evaluation of efficacy and safety.

21 January 2018

1 reference

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

The effect of deprenyl and levodopa on the progression of Parkinson's disease

21 January 2018

1 reference

Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease

21 January 2018

1 reference

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group

21 January 2018

1 reference

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.16353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9762373%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference